Excretion of MBDB and BDB in urine, saliva, and sweat following single oral administration

Journal of Analytical Toxicology

Volumn 21, Issue 7, 1997, Pages 570-575

  Kintz, Pascal ^a  

^a INSTITUT DE MÉDECINE LÉGALE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE DERIVATIVE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; DRUG ABUSE; DRUG EXCRETION; GAS CHROMATOGRAPHY; HUMAN; MALE; MASS SPECTROMETRY; SALIVA LEVEL; SWEAT; URINE LEVEL;

EID: 0030666766     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/21.7.570     Document Type: Article

References (21)

1. V. Fineschi and A. Masti. Fatal poisoning by MDMA (ecstasy) and MDEA: a case report. Int. J. Leg. Med. 108: 272-75 (1996).
2. H.K. Hensslin, K.A. Kovar, and H.H. Maurer. Toxicological detection of the designer drug 3,4-methylenedioxyethylamphetamine (MDE, "Eve") and its metabolites in urine by gas chromatography-mass spectrometry and fluorescence polarization immuno-assay. J. Chromatogr. B 683:189-97 (1996).
3. D.E. Cox and K.R. Williams. "ADAM" or "EVE"? A toxicological conundrum. Forensic Sci. Int. 77: 101-108 (1996).
4. K. Verebey, J. Alrazi, and J.H. Jaffe. The complications of "Ecstasy" (MDMA). J. Am. Med. Assoc. 259: 1649-50 (1988).
5. G. Greer and R. Tolbert. Subjective reports of the effects of 3,4-methylenedioxymethamphetamine in a clincal setting. J. Psychoactive Drugs 18: 319-27 (1986).
6. J. Strafer. MDMA: psychedelic drug faces regulation. Psychol. Today 19: 68-69 (1985).
7. A.R.W. Forrest, J.H. Galloway, I.D. Marsh, G.A. Strachan, and J.C. Clark. A fatal overdose with 3,4-methylenedioxyamphetamine derivatives. Forensic Sci. Int. 64: 57-59 (1994).
8. D.E. Nichols. Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens. J. Psychoactive Drugs 18: 305-13 (1986).
9. J.F. Nash and D.E. Nichols. Microdialysis studies on 3,4-methylene-dioxyamphetamine and structurally related analogues. Eur. J. Pharmacol. 200: 53 (1991).
10. 3H-Monoamine releasing and uptake inhibition properties of 3,4-methylendioxy-methamphetamine and p-chloroamphetamine analogues. Eur. J. Pharmacol. 200: 9-16 (1991).
11. M.P. Johnson and D.E. Nichols. Neurotoxic effects of the alpha-ethyl homologue of MDMA following subacute administration. Pharmacol. Biochem. Behav. 33: 105-108 (1989).
12. C.W. Callaway, M.P. Johnson, L.H. Gold, D.E. Nichols, and M.A. Geyer. Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists. Psychopharmacol. 104: 293-301 (1991).
13. R. Kronstrand. Identification of N-methyl-1-(3,4-methylene-diosyphenyl)-2-butanamine (MBDB) in urine from drug users. J. Anal. Toxicol. 20: 512-16 (1996).
14. H.H. Maurer. On the metabolism and the toxicological analysis of methylendioxyphenylalkylamine designer drugs by gas chromatography-mass spectrometry. Ther. Drug Monit. 18: 465-70 (1996).
15. FT. Noggle, C.R. Clark, S. Andurkar, and J. De Ruiter. Methods for the analysis of 1-(3,4-methylenedioxyphenyl)-2-butanamine and N-methyl-1-(3,4-methylenedioxyphenyl)-2-propanamine (MDMA). J. Chromatogr. Sci. 29: 103-106 (1991).
16. P. Rösner and T. Junge. N-Methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine, a representative of a new class of street drugs. Microgram 27: 411-18 (1994).
17. F.T. Noggle, C.R. Clark, and J. De Ruiter. Chromatographic and masss spectrometric analysis of N-methyl-1-(3,4-methylenen-dioxyphenyl)-2-butanamine and regio-isomeric derivatives. Microgram 28: 321-28 (1995).
18. A.M. Pfeifer and K.A. Kovar. Identification of LSD, MBDB, and atropine in real samples with on-line HPTLC-FTIR coupling. J. Planar Chromatogr. 8: 388-92 (1995).
19. E.J. Cone. Saliva testing for drugs of abuse. Ann. N.Y. Acad. Sci. 694: 91-127 (1990).
20. P. Kintz, A. Tracqui, and P. Mangin. Sweat testing for benzodiazepines. J. Forensic. Sci. 41: 851-854 (1996).
21. P. Kintz, A. Tracqui, P. Mangin, and Y. Edel. Sweat testing in opioid users with a sweat patch. J. Anal. Toxicol. 20: 393-97 (1996).